KetamineOne Capital Share Price Deutsche Boerse AG
Equities
MY00
CA4925531028
Healthcare Facilities & Services
Sales 2020 | - | Sales 2021 | 1.13 1.05 90.34 | Capitalization | 1.79M 1.66M 143M |
---|---|---|---|---|---|
Net income 2020 | 1M 929K 79.87M | Net income 2021 | -31M -28.79M -2.48B | EV / Sales 2020 * | - |
Net cash position 2020 * | - 0 0 | Net cash position 2021 * | - 0 0 | EV / Sales 2021 * | - |
P/E ratio 2020 * |
-
| P/E ratio 2021 * |
-
| Employees | - |
Yield 2020 * |
-
| Yield 2021 * |
-
| Free-Float | 100% |
Managers | Title | Age | Since |
---|---|---|---|
Najla Guthrie
CEO | Chief Executive Officer | - | 31/05/21 |
Terry Zimaro
DFI | Director of Finance/CFO | 49 | 14/06/22 |
Keith White
CTO | Chief Tech/Sci/R&D Officer | - | 31/05/21 |
Members of the board | Title | Age | Since |
---|---|---|---|
Brendan Purdy
BRD | Director/Board Member | 37 | 06/01/21 |
Najla Guthrie
CEO | Chief Executive Officer | - | 31/05/21 |
Natasha Raey
BRD | Director/Board Member | 42 | 17/09/20 |
1st Jan change | Capi. | |
---|---|---|
+20.68% | 85.55B | |
-29.31% | 70.07B | |
+9.65% | 29.06B | |
-8.63% | 17.51B | |
+2.14% | 17.39B | |
+0.39% | 15.38B | |
+6.47% | 13.4B | |
+68.09% | 12.87B | |
+6.43% | 12.77B |